Evoke Pharma, Inc.

Evoke Pharma, Inc.

EVOK
Evoke Pharma, Inc.US flagNASDAQ Capital Market
11.00
USD
+11.00
- -
18.95MMarket Cap

Income Statement (USD)

APIChatGPT
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2011
12/31/2012
12/31/2013
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
3
5
10
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
3
5
10
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
2
5
10
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
2
2
3
13
12
11
11
8
7
13
9
10
12
15
+ Selling, General & Admin
1
1
2
3
4
4
4
4
4
6
9
10
12
15
+ Research & Development
2
1
1
10
8
7
7
4
3
7
1
- -
- -
- -
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-2
-2
-3
-13
-12
-11
-11
-8
-7
-13
-8
-8
-7
-5
- Non-Operating (Income) Loss
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
+ Interest Expense, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
1
- Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
Pretax Income
-2
-2
-3
-13
-12
-11
-12
-8
-7
-13
-9
-8
-8
-5
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-2
-2
-3
-13
-12
-11
-12
-8
-7
-13
-9
-8
-8
-5
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-2
-2
-3
-13
-12
-11
-12
-8
-7
-13
-9
-8
-8
-5
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-2
-2
-3
-13
-12
-11
-12
-8
-7
-13
-9
-8
-8
-5
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-2
-2
-3
-13
-12
-11
-12
-8
-7
-13
-9
-8
-8
-5
EBIT
-2
-2
-3
-13
-12
-11
-11
-8
-7
-13
-8
-8
-7
-5
EBITDA
-2
-2
-3
-13
-12
-11
-11
-8
-7
-13
-8
-8
-7
-5
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-56,678.32
-503.79
-310.37
-143.44
-50.77
EBITA
-2
-2
-3
-13
-12
-11
-11
-8
-7
-13
-8
-8
-7
-5
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-276.68
79.72
85.24
96.1
96.52
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-56,678.32
-503.79
-310.37
-143.44
-50.77
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-57,144.53
-527.66
-327.83
-150.41
-52.22
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
Basic EPS, GAAP
-304.61
-258.49
-172.49
-316.23
-269.13
-165.75
-118.21
-65.62
-46.02
-74.31
-38.2
-31.39
-27.97
-2.81
Basic EPS from Cont Ops
-304.61
-258.49
-172.49
-316.23
-269.13
-165.75
-118.21
-65.62
-46.02
-74.31
-38.2
-31.39
-27.97
-2.81
Diluted Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
Diluted EPS, GAAP
-304.61
-258.49
-172.49
-316.23
-269.13
-165.75
-117.79
-65.62
-46.02
-74.31
-38.2
-31.39
-27.97
-2.81
Diluted EPS from Cont Ops
-304.61
-258.49
-172.49
-316.23
-269.13
-165.75
-117.79
-65.62
-46.02
-74.31
-38.2
-31.39
-27.97
-2.81

Balance Sheet (USD)

APIChatGPT
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2011
12/31/2012
12/31/2013
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Total Current Assets
1
- -
24
15
10
9
8
6
6
9
11
12
7
17
+ Cash, Cash Equivalents & STI
1
- -
24
14
9
9
8
5
6
8
9
10
5
14
+ Cash & Cash Equivalents
1
- -
24
14
9
9
8
5
6
8
9
10
5
14
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
2
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
2
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
- -
1
1
- -
- -
- -
1
1
1
1
1
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
1
- -
25
15
10
9
8
6
6
9
11
12
7
18
+ Payables & Accruals
- -
1
- -
1
1
- -
1
- -
1
6
1
1
3
4
+ Accounts Payable
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
2
2
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
1
- -
1
1
- -
1
- -
- -
5
- -
- -
2
2
+ ST Debt
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
5
5
+ ST Borrowings
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
5
5
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
1
1
1
1
1
1
1
1
1
1
1
1
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
1
1
1
1
1
1
1
1
1
1
1
1
Total Current Liabilities
- -
1
2
2
2
1
2
2
2
8
1
2
10
10
+ LT Debt
- -
1
2
4
4
- -
- -
- -
- -
5
5
5
- -
- -
+ LT Borrowings
- -
1
2
4
4
- -
- -
- -
- -
5
5
5
5
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
18
- -
- -
- -
4
4
- -
- -
- -
1
1
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
18
- -
- -
- -
4
4
- -
- -
- -
1
1
- -
- -
Total Noncurrent Liabilities
- -
19
2
4
4
4
4
- -
- -
5
6
6
- -
- -
Total Liabilities
- -
20
4
6
6
6
6
2
2
13
7
8
10
10
+ Preferred Equity and Hybrid Capital
18
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
- -
44
45
52
63
73
83
90
96
111
120
121
136
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
44
45
52
63
73
83
90
96
111
120
121
136
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-18
-20
-23
-36
-48
-59
-71
-79
-86
-99
-107
-116
-123
-129
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
1
-20
21
9
3
4
2
4
4
-3
4
4
-3
7
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
1
-20
21
9
3
4
2
4
4
-3
4
4
-3
7
Total Liabilities & Equity
1
- -
25
15
10
9
8
6
6
9
11
12
7
18
Shares Outstanding
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Debt
-1
1
-21
-10
-4
-9
-8
-5
-6
-3
-4
-5
5
-9
Net Debt to Equity
-151.69
-4.39
-100.28
-107.01
-124.45
-237.8
-354.58
-132.14
-129.3
92.23
-116.59
-118.58
-203.93
-122.15
Tangible Common Equity Ratio
-1,950.03
-16,945.82
84.78
60.32
36.35
40.75
27.27
71.12
68.49
-34.07
33.62
34.47
-36.49
40.17
Current Ratio
2.71
0.2
10.69
8.24
5.19
6.58
3.82
3.46
3.1
1.23
7.51
7.08
0.71
1.66
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
- -
-620.17
-1,143.41
-394.97
-481.7
-1,783.56

Cash Flow Statement (USD)

APIChatGPT
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2011
12/31/2012
12/31/2013
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
+ Net Income
-2
-2
-3
-13
-12
-11
-12
-8
-7
-13
-9
-8
-8
-5
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
- -
- -
1
2
2
3
1
1
2
2
1
2
1
+ Stock-Based Compensation
- -
- -
- -
1
2
2
2
2
1
2
2
1
1
1
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
1
1
+ Chg in Non-Cash Work Cap
-1
- -
- -
1
- -
- -
1
-1
- -
5
-6
- -
1
-1
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-2
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc (Dec) in Accts Payable
-1
- -
- -
1
- -
- -
1
- -
- -
6
-6
1
1
- -
+ Inc (Dec) in Other
- -
- -
-1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-3
-2
-3
-12
-10
-9
-9
-7
-6
-7
-12
-7
-5
-5
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
25
- -
5
14
7
5
6
4
15
7
- -
7
+ Increase in Capital Stock
- -
- -
25
- -
5
14
7
5
6
4
15
7
- -
7
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
-1
1
2
2
- -
-9
- -
- -
- -
5
- -
- -
- -
- -
+ Cash From Debt
- -
1
2
4
- -
- -
- -
- -
- -
5
- -
- -
- -
- -
+ Repayments of Debt
-1
- -
- -
-3
- -
-9
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
- -
- -
- -
- -
4
- -
- -
- -
- -
-1
- -
- -
8
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
1
27
1
5
9
7
5
6
9
13
7
- -
14
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
-3
-1
24
-10
-5
- -
-1
-2
- -
2
1
1
-5
9
EBITDA
-2
-2
-3
-13
-12
-11
-11
-8
-7
-13
-8
-8
-7
-5
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-56,678.32
-503.79
-310.37
-143.44
-50.77
Free Cash Flow
-3
-2
-3
-12
-10
-9
-9
-7
-6
-7
-12
-7
-5
-5
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-19
-1
-10
-10
-18
-9
-7
-6
-2
-12
-7
-5
-5
Free Cash Flow per Basic Share
-367.01
-224.2
-184.89
-274.54
-233.03
-134.28
-84.26
-60.53
-37.21
-37.45
-55.27
-25.18
-17.9
-2.87
Price/Free Cash Flow
- -
- -
-5.8
-3.1
-2.04
-2.17
-3.88
-5.9
-6.27
-9.92
-1.43
-1.28
-0.7
-1.54
Cash Flow to Net Income
1.2
0.87
1.07
0.87
0.87
0.81
0.71
0.92
0.81
0.5
1.45
0.8
0.64
1.02
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -